The benefits and challenges of multiple health behavior change in research and in practice
Open Access
- 28 February 2010
- journal article
- Published by Elsevier BV in Preventive Medicine
- Vol. 50 (1-2), 26-29
- https://doi.org/10.1016/j.ypmed.2009.11.009
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Zanamivir Pharmacokinetics and Pulmonary Penetration into Epithelial Lining Fluid following Intravenous or Oral Inhaled Administration to Healthy Adult SubjectsAntimicrobial Agents and Chemotherapy, 2011
- Generation and Characterization of Recombinant Pandemic Influenza A(H1N1) Viruses Resistant to Neuraminidase InhibitorsThe Journal of Infectious Diseases, 2011
- Prophylactic Activity of Intramuscular Peramivir in Mice Infected with a Recombinant Influenza A/WSN/33 (H1N1) Virus Containing the H274Y Neuraminidase MutationAntimicrobial Agents and Chemotherapy, 2010
- Rapid Selection of Oseltamivir‐ and Peramivir‐Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised HostsClinical Infectious Diseases, 2010
- Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populationsJournal of Antimicrobial Chemotherapy, 2010
- In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza VirusesAntimicrobial Agents and Chemotherapy, 2009
- Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and MiceScience, 2009
- In vitro and in vivo characterization of new swine-origin H1N1 influenza virusesNature, 2009
- Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008Antimicrobial Agents and Chemotherapy, 2008
- Importance of Neuraminidase Active-Site Residues to the Neuraminidase Inhibitor Resistance of Influenza VirusesJournal of Virology, 2006